Literature DB >> 3818781

Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

R J Lellé, W Heidenreich, G Stauch, I Wecke, J Gerdes.   

Abstract

Certain types of benign breast disease (BBD) carry an increased risk of malignancy. Several morphological criteria such as an atypia score are used to define this group, and the use of a kinetic parameter may provide additional information. Therefore, the growth fractions of 120 benign breast lesions were determined using the monoclonal antibody Ki-67. The values obtained range from 0.3% to 10.8% (average 3.1% +/- 2.2%) compared to breast carcinomas with an average of 15.3% +/- 10.1%, range 0.8% to 47.8%. All specimens were classified using the terminology of Azzopardi. The prevailing histological entities were cystic disease, fibroadenoma, and blunt duct adenosis. Between these groups no differences in growth fractions were observed. Postmenopausal patients had slightly lower values than premenopausal women. Further prospective studies are needed to evaluate whether those cases of BBD with a high number of Ki-67 positive cells have an increased risk of breast cancer, independently from conventional histological classifications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818781     DOI: 10.1007/bf00389970

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis.

Authors:  J Russo; I H Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

2.  [General explanations on the histomorphology of breast diseases].

Authors:  K Prechtel
Journal:  Fortschr Med       Date:  1974-03-21

Review 3.  The kinetics of tumour cell proliferation and radiotherapy.

Authors:  M Tubiana
Journal:  Br J Radiol       Date:  1971-05       Impact factor: 3.039

Review 4.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  The epidemiology of benign breast disease.

Authors:  V L Ernster
Journal:  Epidemiol Rev       Date:  1981       Impact factor: 6.222

7.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

8.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.

Authors:  J S Meyer
Journal:  Hum Pathol       Date:  1977-01       Impact factor: 3.466

9.  Beware of breast fibroadenomas in middle-aged women.

Authors:  L Deschênes; S Jacob; J Fabia; A Christen
Journal:  Can J Surg       Date:  1985-07       Impact factor: 2.089

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  5 in total

1.  Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.

Authors:  S Y Iftikhar; R J Steele; S Watson; P D James; K Dilks; J D Hardcastle
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

2.  A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis.

Authors:  P E Van Erp; S De Mare; J J Rijzewijk; P C Van de Kerkhof; F W Bauer
Journal:  Histochem J       Date:  1989-06

3.  Accurate determination of S-phase fraction in proliferative cells by dual fluorescence and peroxidase immunohistochemistry with 5-bromo-2'-deoxyuridine (BrdU) and Ki67 antibodies.

Authors:  Rina Tanaka; Motomi Tainaka; Takumi Ota; Naoki Mizuguchi; Hiroyuki Kato; Shoichi Urabe; Yulin Chen; Jean-Michel Fustin; Yoshiaki Yamaguchi; Masao Doi; Shinshichi Hamada; Hitoshi Okamura
Journal:  J Histochem Cytochem       Date:  2011-05-06       Impact factor: 2.479

4.  Analysis of human mammary fibroadenoma by Ki-67 index in the follicular and luteal phases of menstrual cycle.

Authors:  M F Rego; M A L H Navarrete; G Facina; R Falzoni; R Silva; E C Baracat; A C P Nazario
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

5.  In vivo cell kinetics in breast carcinogenesis.

Authors:  M Bai; N J Agnantis; S Kamina; A Demou; P Zagorianakou; A Katsaraki; P Kanavaros
Journal:  Breast Cancer Res       Date:  2001-06-05       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.